Diabetes Type 2

192 clinical trials · Condition

Record	Firm	Date
Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy (NCT00556465)	Shiraz University of Medical Sciences	2007-01-01
The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans (NCT01953393)	Rigshospitalet, Denmark	2006-04-01
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up (NCT00309244)	Mannkind Corporation	2006-02-01
Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus (NCT00539890)	Mannkind Corporation	2005-11-01
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy (NCT00464880)	Novartis	2005-09-01
Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes (NCT00461136)	Novartis	2005-08-01
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes (NCT00308737)	Mannkind Corporation	2005-06-01
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes (NCT00141232)	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	2004-11-01
Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes (NCT00934414)	Mannkind Corporation	2004-08-01
Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes (NCT00898950)	University of Portsmouth	2004-08-01
Dietary Interventions in Type 2 Obese Diabetic Patients in the Community (NCT00520182)	Ben-Gurion University of the Negev	2004-03-01
Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes: Diabetes Project Aalst (NCT00824499)	Universiteit Antwerpen	2004-02-01
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control (NCT00246987)	Bristol-Myers Squibb	2003-06-01
The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle (NCT01799850)	East Tennessee State University	2002-03-01
Genetics of Beta Cell Failure in Mexican Americans (NCT03301519)	University of Southern California	2001-07-01

Track Diabetes Type 2 automatically

Every clearance here is in the API, with alerts when new ones post.